
Kamada Ltd. KMDA
€ 6.70
-2.8%
Quartalsbericht 2025-Q4
hinzugefügt 06.05.2026
Kamada Ltd. Finanzkreislauf 2011-2026 | KMDA
Finanzkreislauf Jährlich Kamada Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 163 | 194 | 154 | 169 | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 194 | 154 | 170 |
Finanzkreislauf anderer Aktien in der Pharmaeinzelhändler
| Name | Finanzkreislauf | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
3.11 K | - | 5743.5 % | $ 69.7 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-3.12 K | - | 1.35 % | $ 17.8 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
205 | $ 16.93 | -2.11 % | $ 791 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
AstraZeneca PLC
AZN
|
-58 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
21.2 | $ 7.44 | -4.98 % | $ 204 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
AbCellera Biologics
ABCL
|
173 | $ 4.03 | -8.33 % | $ 1.2 B | ||
|
Compugen Ltd.
CGEN
|
-82.7 | $ 2.86 | -5.78 % | $ 267 M | ||
|
Autolus Therapeutics plc
AUTL
|
119 | $ 1.57 | -1.26 % | $ 418 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Coherus BioSciences
CHRS
|
149 | $ 1.58 | -3.07 % | $ 185 M | ||
|
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
AIkido Pharma
AIKI
|
-1.92 | - | 1.93 % | $ 17.4 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
-193 | $ 0.73 | -0.98 % | $ 33.4 M | ||
|
Esperion Therapeutics
ESPR
|
99.7 | $ 3.13 | 0.32 % | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
115 | $ 29.76 | -0.67 % | $ 801 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
Exelixis
EXEL
|
-8.32 | $ 49.98 | -2.19 % | $ 13.6 B | ||
|
Arcutis Biotherapeutics
ARQT
|
158 | $ 21.8 | 1.07 % | $ 2.77 B | ||
|
Fortress Biotech
FBIO
|
-74.9 | $ 2.39 | 3.83 % | $ 66.7 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-2.85 K | - | -11.43 % | $ 502 K | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Fennec Pharmaceuticals
FENC
|
148 | $ 9.58 | 3.7 % | $ 274 M |